Abstract
Transitioning from lab manufacture to commercialization presents significant challenges, no matter what area you’re working in. Cell and gene therapies are no different and production quantities must scale at multiple stages, first to support clinical trials and then when they reach the market.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have